Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
VAV1 and BAFF, via NFκB pathway, are genetic risk factors for myasthenia gravis.
Avidan N, Le Panse R, Harbo HF, Bernasconi P, Poulas K, Ginzburg E, Cavalcante P, Colleoni L, Baggi F, Antozzi C, Truffault F, Horn-Saban S, Pöschel S, Zagoriti Z, Maniaol A, Lie BA, Bernard I, Saoudi A, Illes Z, Casasnovas Pons C, Melms A, Tzartos S, Willcox N, Kostera-Pruszczyk A, Tallaksen C, Mantegazza R, Berrih-Aknin S, Miller A. Avidan N, et al. Among authors: zagoriti z. Ann Clin Transl Neurol. 2014 May;1(5):329-39. doi: 10.1002/acn3.51. Epub 2014 Apr 11. Ann Clin Transl Neurol. 2014. PMID: 25356403 Free PMC article.
Recent advances in genetic predisposition of myasthenia gravis.
Zagoriti Z, Kambouris ME, Patrinos GP, Tzartos SJ, Poulas K. Zagoriti Z, et al. Biomed Res Int. 2013;2013:404053. doi: 10.1155/2013/404053. Epub 2013 Nov 5. Biomed Res Int. 2013. PMID: 24294607 Free PMC article. Review.
Myasthenia gravis genome-wide association study implicates AGRN as a risk locus.
Topaloudi A, Zagoriti Z, Flint AC, Martinez MB, Yang Z, Tsetsos F, Christou YP, Lagoumintzis G, Yannaki E, Zamba-Papanicolaou E, Tzartos J, Tsekmekidou X, Kotsa K, Maltezos E, Papanas N, Papazoglou D, Passadakis P, Roumeliotis A, Roumeliotis S, Theodoridis M, Thodis E, Panagoutsos S, Yovos J, Stamatoyannopoulos J, Poulas K, Kleopa K, Tzartos S, Georgitsi M, Paschou P. Topaloudi A, et al. Among authors: zagoriti z. J Med Genet. 2022 Aug;59(8):801-809. doi: 10.1136/jmedgenet-2021-107953. Epub 2021 Aug 16. J Med Genet. 2022. PMID: 34400559
PheWAS and cross-disorder analysis reveal genetic architecture, pleiotropic loci and phenotypic correlations across 11 autoimmune disorders.
Topaloudi A, Jain P, Martinez MB, Bryant JK, Reynolds G, Zagoriti Z, Lagoumintzis G, Zamba-Papanicolaou E, Tzartos J, Poulas K, Kleopa KA, Tzartos S, Georgitsi M, Drineas P, Paschou P. Topaloudi A, et al. Among authors: zagoriti z. Front Immunol. 2023 Sep 21;14:1147573. doi: 10.3389/fimmu.2023.1147573. eCollection 2023. Front Immunol. 2023. PMID: 37809097 Free PMC article.
Population-specific documentation of pharmacogenomic markers and their allelic frequencies in FINDbase.
Georgitsi M, Viennas E, Gkantouna V, Christodoulopoulou E, Zagoriti Z, Tafrali C, Ntellos F, Giannakopoulou O, Boulakou A, Vlahopoulou P, Kyriacou E, Tsaknakis J, Tsakalidis A, Poulas K, Tzimas G, Patrinos GP. Georgitsi M, et al. Among authors: zagoriti z. Pharmacogenomics. 2011 Jan;12(1):49-58. doi: 10.2217/pgs.10.169. Pharmacogenomics. 2011. PMID: 21174622
18 results